| abstract |
The present invention relates to a compound of formula (I): [Wherein all variables are as defined herein.] ] Novel trifluoromethyl-oxadiazole derivatives and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, pharmaceutical combinations thereof, and pharmaceuticals, particularly neurodegeneration, inhibition of HDAC4, muscle atrophy or diabetes / metabolic It relates to its use in the treatment of syndrome. |